Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02536157
Other study ID # 12020625
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 2015
Est. completion date January 2017

Study information

Verified date March 2019
Source National Health Service, United Kingdom
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Which splinting method produces the best outcomes (in range of movement, pain and function) in the non-operative treatment of stable volar plate injuries in adults?

The volar plate is a ligament located at the middle knuckle (proximal interphalangeal joint - PIPJ) of the finger. It is commonly injured through hyperextension, for example a ball hitting the fingertip. Current treatment in the Hand Therapy Unit involves splinting the injured joint dorsally (on the back of the finger) into 20⁰ flexion (bent) using thermoplastic material. However, there is a potential risk of developing permanent stiffness of the PIPJ into straightening, once the volar plate ligament heals. To reduce this risk, the study aims to investigate if using a volar (on the front of the finger) gutter splint in 0⁰ flexion (straight), which still prevents hyperextension, achieves better outcomes. There is no existing high-quality evidence comparing these two methods.

This is a randomised controlled trial. For the purposes of this study, the current treatment of a 20° dorsal block splint will act as the control group. The intervention group will be the volar gutter splint group. A convenience sample will be used and all patients (over 16 years old) presenting to the Mid Yorkshire Hospitals NHS Trust's Hand Therapy Unit will be invited to participate in the study, with consideration to inclusion/exclusion criteria. Participants will be randomised into one of two groups through the use of a random number generator. The outcomes assessed will be range of movement, pain and function. These will be measured at initial assessment, four and twelve weeks. These are all average normal time intervals that patients are seen. Each splint is worn for four weeks and participants will receive standardised advice, exercises and treatment.


Recruitment information / eligibility

Status Completed
Enrollment 42
Est. completion date January 2017
Est. primary completion date January 2017
Accepts healthy volunteers No
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria:

1. All stable volar plate injuries.

2. Aged 16 and older.

3. Male and female.

4. Acute presentation within 2 weeks of injury.

5. All ethnic groups speaking English.

Exclusion Criteria:

1. Vulnerable patient groups or those lacking capacity.

2. Previous injury or pathology involving the same digit.

3. Surgical intervention

4. Unstable proximal interphalangeal joint.

5. Concomitant tendon or additional bony injury outside the traditional Eaton classification types of volar plate injury.

6. The DASH outcome measure is available and validated in 27 languages. However, those who do not speak/understand English well will unfortunately be excluded. This is an educational project and therefore there is no funding to use a translator service.

7. Volar plate injuries are just as common in children and teenagers as adults. But under 16s will be excluded from this study as the DASH questionnaire has only been assumed valid in adults. There is no research investigating its use in younger age-groups.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Thermoplastic splinting


Locations

Country Name City State
United Kingdom Hand Therapy Unit, Mid Yorkshire Hospitals NHS Trust, Pinderfields General Hospital, Aberford Road, Wakefield West Yorkshire

Sponsors (2)

Lead Sponsor Collaborator
National Health Service, United Kingdom University of Bradford

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Range of movement measured with a Jamar finger goniometer. Range of movement measured with a Jamar finger goniometer. One week
Primary Range of movement measured with a Jamar finger goniometer. Range of movement measured with a Jamar finger goniometer. Four weeks
Primary Range of movement measured with a Jamar finger goniometer. Range of movement measured with a Jamar finger goniometer. Twelve weeks
Secondary Pain measured using a 100mm visual analogue scale. Measured using a 100mm visual analogue scale. One, four and twelve weeks
Secondary Function of the upper limb measured using the DASH questionnaire. Disabilities of the Shoulder, Arm and Hand Questionnaire. One, four and twelve weeks